サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1362927

口腔乾燥症治療薬の市場規模、シェア、動向分析レポート：タイプ別、製品別、地域別、セグメント別予測、2023年～2030年

Xerostomia Therapeutics Market Size, Share & Trends Analysis Report By Type (OTC, Prescription), By Product (Salivary Stimulants, Salivary Substitutes, Dentifrices), By Region, And Segment Forecasts, 2023 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
口腔乾燥症治療薬の市場規模、シェア、動向分析レポート：タイプ別、製品別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月07日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

口腔乾燥症治療薬市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の口腔乾燥症治療薬市場規模は、2023年から2030年にかけてCAGR 3.8%で拡大し、2030年には27億米ドルに達する見込みです。

口腔乾燥症製品に対する有利な償還政策の増加や、関連疾患に対する意識の高まりが、市場成長に寄与する主な要因です。

さらに、口腔乾燥症やシェーグレン症候群、糖尿病、高血圧、パーキンソン病などの関連疾患の有病率の増加は、市場全体にプラスの影響を与えています。コルゲート・パルモリーブ社によると、米国では2,500万人がドライマウスを経験しています。Sjogren Syndrome Foundation of Americaによると、約400万人のアメリカ人が自己免疫疾患であるシェーグレン症候群に苦しんでいます。

口腔乾燥症や関連疾患に対する認識を高めるためのイニシアチブの高まりが、成長の原動力になると予想されます。例えば、米国シェーグレン症候群財団は、米国とカナダで啓発プログラムを実施し、同症候群に苦しむ患者を支援しています。2012年、同財団は「5-Year Breakthrough Goal」を立ち上げ、2017年までに同症候群の診断に要する期間を2.5年未満に短縮することを目指しています。

さらに、大手企業は新興企業の買収に注力し、ドライマウス症状に対する認識を高めるためのプログラムを実施しています。例えば、Church &Dwight Co., Inc.のブランドであるOrajelは、デジタルマーケティング代理店であるiCrossingの協力を得て、口腔ケアの重要性を保護者に啓蒙するキャンペーンを開始しました。

口腔乾燥症治療薬市場レポート・ハイライト

  • 口腔乾燥症治療薬の世界市場規模は2022年に20億米ドルと推定され、2023年から2030年にかけてCAGR 3.8%で成長すると予測されます。
  • 入手のしやすさ、手頃な価格、高い効率性などの要因により、OTCセグメントが市場を独占しています。
  • 歯科用剤セグメントは予測期間中に最も速いCAGRで成長すると予想されます。
  • 北米は、ドライマウスの原因となる疾患の有病率の増加や口腔乾燥症に対する意識向上のためのイニシアチブの高まりなどの要因により、2022年に最大のシェアを占めました。
  • アジア太平洋地域は、この疾患に対する意識の高まりとヘルスケア支出の増加により、今後10年間で有利な成長が見込まれています。
  • グラクソ・スミスクライン社、チャーチ・アンド・ドワイト社、コルゲート・パルモリーブ社などの主要企業が、世界の口腔乾燥症治療薬市場を独占しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 口腔乾燥症治療薬市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • 口腔乾燥症治療薬市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 口腔乾燥症治療薬：タイプの推定・動向分析

  • 口腔乾燥症治療薬市場：重要なポイント
  • 口腔乾燥症治療薬市場：動向と市場シェア分析、2022年および2030年
  • 店頭販売（OTC）
    • 店頭
  • 処方箋
    • 2018年から2030年の処方箋市場推計・予測

第5章 口腔乾燥症治療薬：製品推定・動向分析

  • 口腔乾燥症治療薬市場：重要なポイント
  • 口腔乾燥症治療薬市場：動向と市場シェア分析、2022年および2030年
  • 唾液分泌促進剤
  • 唾液代替品
  • 歯みがき剤

第6章 口腔乾燥症治療薬市場：地域推定・動向分析

  • 地域別の見通し
  • 口腔乾燥症治療薬システム市場：地域別、主要マーケットプレースのポイント
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Acacia Pharma
    • Parnell Pharmaceuticals, Inc.
    • Pfizer, Inc.
    • GlaxoSmithKline plc
    • Church & Dwight Co., Inc.
    • Lupin
    • Sun Pharmaceutical Industries, Ltd.
    • Hikma Pharmaceuticals PLC
    • Pendopharm
    • OraCoat
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 7 Canada xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 9 Europe xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 10 Europe xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 11 Europe xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 14 UK xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 16 France xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 17 France xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 18 Italy xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 20 Spain xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 22 Sweden xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 23 Sweden xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 24 Norway xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 25 Norway xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Denmark xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 28 APAC xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 29 APAC xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 30 APAC xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 31 Japan xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 32 Japan xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 33 China xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 34 China xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 35 India xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 36 India xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 37 Australia xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 38 Australia xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 39 Thailand xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 40 Thailand xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 41 South Korea xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 42 South Korea xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 43 Latin America xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 44 Latin America xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 45 Latin America xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 48 Mexico xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 50 Argentina xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa xerostomia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 59 UAE xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)
  • Table 61 Kuwait xerostomia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait xerostomia therapeutics market, by product, 2018 - 2030 (USD Million)

List of Figure

Fig. 1 Market research process

Fig. 2 Data triangulation techniques

Fig. 3 Primary research pattern

Fig. 4 Market research approaches

Fig. 5 Value-chain-based sizing & forecasting

Fig. 6 QFD modeling for market share assessment

Fig. 7 Market formulation & validation

Fig. 8 Xerostomia therapeutics: market outlook

Fig. 9 Xerostomia therapeutics competitive insights

Fig. 10 Parent market outlook

Fig. 11 Related/ancillary market outlook

Fig. 12 Penetration and growth prospect mapping

Fig. 13 Industry value chain analysis

Fig. 14 Xerostomia therapeutics market driver impact

Fig. 15 Xerostomia therapeutics market restraint impact

Fig. 16 Xerostomia therapeutics market strategic initiatives analysis

Fig. 17 Xerostomia therapeutics market: type movement analysis

Fig. 18 Xerostomia therapeutics market: type outlook and key takeaways

Fig. 19 Over-the-counter (OTC) market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 20 Prescription market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 21 Xerostomia therapeutics market: product movement analysis

Fig. 22 Xerostomia therapeutics market: product outlook and key takeaways

Fig. 23 Salivary stimulants market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 24 Salivary substitutes market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 25 Dentifrices market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 26 Xerostomia therapeutics market: material movement analysis

Fig. 27 Global xerostomia therapeutics market: regional movement analysis

Fig. 28 Global xerostomia therapeutics market: regional outlook and key takeaways

Fig. 29 North America, by country

Fig. 30 North America market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 31 U.S. market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 32 Canada market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 33 Europe. market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 34 UK market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 35 Germany market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 36 France market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 37 Italy market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 38 Spain market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 39 Sweden market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 40 Norway market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 41 Denmark market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 42 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 43 China market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 44 Japan market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 45 India market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 46 Australia market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 47 Thailand market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 48 South Korea market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 49 Latin America market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 50 Brazil market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 51 Mexico market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 52 Argentina market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 53 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 54 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 55 South Africa market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 56 UAE market estimates and forecast, 2018 - 2030 (USD Million)

Fig. 57 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

目次
Product Code: GVR-1-68038-628-8

Xerostomia Therapeutics Market Growth & Trends:

The global xerostomia therapeutics market size is expected to reach USD 2.70 billion by 2030, expanding at a CAGR of 3.8% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Increase in favorable reimbursement policies for xerostomia products and growing awareness about associated diseases are the major factors contributing toward market growth.

In addition, increasing prevalence of xerostomia and associated diseases such as Sjogren's syndrome, diabetes, hypertension, and Parkinson's disease has a positive impact on the overall market. According to Colgate-Palmolive Company, 25 million people in the U.S. experience dry mouth. According to Sjogren Syndrome Foundation of America, around 4 million Americans are suffering from Sjogren's syndrome, an autoimmune disorder.

Growing initiatives for raising awareness about xerostomia and associated diseases are expected to drive growth. For instance, Sjogren Syndrome Foundation of America conducts awareness programs and supports patients suffering from the syndrome in the U.S. and Canada. In 2012, the foundation launched the "5-Year Breakthrough Goal" with an aim to reduce the time required to diagnose the condition to less than 2.5 years by 2017.

Furthermore, major players focus on acquiring emerging companies and conduct programs to raise awareness about dry mouth condition. For instance, Orajel, a brand of Church & Dwight Co., Inc. initiated a campaign with the help of iCrossing, a digital marketing agency to educate parents about the importance of oral care.

Xerostomia Therapeutics Market Report Highlights:

  • The global xerostomia therapeutics market size was estimated at USD 2.0 billion in 2022 and is expected to grow with CAGR of 3.8% from 2023 to 2030
  • The OTC segment dominated the market due to factors such as ease in availability, affordability, and higher efficiency
  • The dentifrices segment is expected to grow at the fastest CAGR over the forecast period.
  • North America held the largest share in 2022 owing to factors such as increasing prevalence of diseases resulting in dry mouth and growing initiatives for raising awareness about xerostomia
  • The Asia Pacific region is anticipated to witness lucrative growth over the next decade due to increasing awareness of the disease and growing healthcare expenditure
  • Some of the key players such as GlaxoSmithKline plc; Church & Dwight Co., Inc.; and Colgate-Palmolive Company dominated the global xerostomia therapeutics market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Product
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Xerostomia Therapeutics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Xerostomia Therapeutics Market Analysis Tools
    • 3.4.1. Industry analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Xerostomia Therapeutics: Type Estimates & Trend Analysis

  • 4.1. Xerostomia Therapeutics Market: Key Takeaways
  • 4.2. Xerostomia Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Over-the-counter (OTC)
    • 4.3.1. Over-the-counter (OTC) market estimates and forecast 2018 to 2030 (USD million)
  • 4.4. Prescription
    • 4.4.1. Prescription market estimates and forecast 2018 to 2030 (USD million)

Chapter 5. Xerostomia Therapeutics: Product Estimates & Trend Analysis

  • 5.1. Xerostomia Therapeutics Market: Key Takeaways
  • 5.2. Xerostomia Therapeutics Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Salivary Stimulants
    • 5.3.1. Salivary stimulants market estimates and forecast 2018 to 2030 (USD million)
  • 5.4. Salivary Substitutes
    • 5.4.1. Salivary substitutes market estimates and forecast 2018 to 2030 (USD Million)
  • 5.5. Dentifrices
    • 5.5.1. Dentifrices market estimates and forecast 2018 to 2030 (USD million)

Chapter 6. Xerostomia Therapeutics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Xerostomia Therapeutics System Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. China
      • 6.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Market estimates and forecast, 2018 - 2030 (Volume, Thousand)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Acacia Pharma
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Type benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Parnell Pharmaceuticals, Inc.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Type benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Pfizer, Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Type benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. GlaxoSmithKline plc
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Type benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Church & Dwight Co., Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Type benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Lupin
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Type benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Sun Pharmaceutical Industries, Ltd.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Type benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Hikma Pharmaceuticals PLC
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Type benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Pendopharm
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Type benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. OraCoat
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Type benchmarking
      • 7.2.10.4. Strategic initiatives